Nippon Chemiphar Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Nippon Chemiphar Co., Ltd. made a loss over the last year. Nippon Chemiphar Co., Ltd. owes ¥0.63 for every ¥1 it owns. Net profit fell 33% in the year to Mar 2026, and shrank 16% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossNippon Chemiphar Co., Ltd. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.29The share price is 0.29 times Nippon Chemiphar Co., Ltd.'s book value per share, lower than almost all Healthcare companies in Japan.
Market cap
¥5.6 BThe total market value of all of Nippon Chemiphar Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 79% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥19.4 BWhat Nippon Chemiphar Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥5,342Net worth divided by the number of shares. The share price of ¥1,535 is 0.3 times this, which is the P/B above.
Return on equity (ROE)
-0.7%Nippon Chemiphar Co., Ltd. lost 0.7% of its shareholders' money over the last year, lower than 74% of Healthcare companies in Japan.
Owes vs Owns
0.63×Nippon Chemiphar Co., Ltd. owes ¥0.63 for every ¥1 it owns (moderate), higher than 77% of Healthcare companies in Japan.
Dividend yield
3.27%Nippon Chemiphar Co., Ltd. pays 3.27% of its share price as dividends a year, higher than 65% of dividend-paying Healthcare companies in Japan.
Revenue growth
+2%Revenue rose 2% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Profit growth
-33%Net profit fell 33% in the year to Mar 2026, and shrank 16% a year on average over 3 years.
Profit margin
0.6%Nippon Chemiphar Co., Ltd. keeps ¥1 of every ¥100 of revenue as net profit.
Cash quality
3.1×Cash from Nippon Chemiphar Co., Ltd.'s business was 3.1× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
0.8×Nippon Chemiphar Co., Ltd.'s operating profit covered its interest costs 0.8 times in the year to Mar 2026.
Cash vs debt
Net debtNippon Chemiphar Co., Ltd. had ¥11.2 B more debt than cash (net debt) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Nippon Chemiphar Co., Ltd.: ¥5.6 B ÷ ¥19.4 B (30 Jun 2026) = 0.3.
What is Nippon Chemiphar Co., Ltd.'s return on equity?
Nippon Chemiphar Co., Ltd. lost 0.7% of its shareholders' money over the last year, lower than 74% of Healthcare companies in Japan.
How much does Nippon Chemiphar Co., Ltd. owe compared with what it owns?
Nippon Chemiphar Co., Ltd. owes ¥0.63 for every ¥1 it owns (moderate), higher than 77% of Healthcare companies in Japan.
Does Nippon Chemiphar Co., Ltd. pay a dividend?
Yes. Nippon Chemiphar Co., Ltd. pays 3.27% of its share price as dividends a year, higher than 65% of dividend-paying Healthcare companies in Japan.
Is Nippon Chemiphar Co., Ltd.'s revenue growing?
Revenue rose 2% in the year to Mar 2026, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.